A detailed history of First Trust Advisors LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 108,408 shares of PCRX stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,408
Previous 78,555 38.0%
Holding current value
$2.11 Million
Previous $2.25 Million 27.37%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$11.7 - $28.46 $349,280 - $849,616
29,853 Added 38.0%
108,408 $1.63 Million
Q2 2024

Aug 13, 2024

BUY
$25.5 - $31.51 $1.12 Million - $1.38 Million
43,848 Added 126.34%
78,555 $2.25 Million
Q1 2024

May 13, 2024

SELL
$27.7 - $35.48 $319,602 - $409,368
-11,538 Reduced 24.95%
34,707 $1.01 Million
Q4 2023

Feb 13, 2024

BUY
$26.32 - $34.31 $1.22 Million - $1.59 Million
46,245 New
46,245 $1.56 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $47.5 $488,703 - $642,675
13,530 New
13,530 $542,000
Q4 2022

Feb 09, 2023

SELL
$38.19 - $57.45 $741,420 - $1.12 Million
-19,414 Reduced 34.73%
36,491 $1.41 Million
Q3 2022

Nov 14, 2022

SELL
$51.24 - $58.89 $790,735 - $908,790
-15,432 Reduced 21.63%
55,905 $2.97 Million
Q2 2022

Aug 12, 2022

BUY
$51.49 - $81.64 $1.88 Million - $2.98 Million
36,469 Added 104.59%
71,337 $4.16 Million
Q1 2022

May 13, 2022

BUY
$60.03 - $76.49 $1.25 Million - $1.59 Million
20,791 Added 147.69%
34,868 $2.66 Million
Q4 2021

Feb 08, 2022

BUY
$47.97 - $62.21 $410,191 - $531,957
8,551 Added 154.74%
14,077 $847,000
Q3 2021

Nov 15, 2021

SELL
$54.64 - $61.3 $1.26 Million - $1.41 Million
-23,010 Reduced 80.63%
5,526 $310,000
Q2 2021

Aug 16, 2021

BUY
$59.18 - $69.99 $532,975 - $630,329
9,006 Added 46.11%
28,536 $1.73 Million
Q1 2021

May 14, 2021

SELL
$59.31 - $78.82 $1.46 Million - $1.94 Million
-24,613 Reduced 55.76%
19,530 $1.37 Million
Q4 2020

Feb 02, 2021

SELL
$50.47 - $66.26 $302,517 - $397,162
-5,994 Reduced 11.96%
44,143 $2.64 Million
Q3 2020

Nov 05, 2020

BUY
$51.97 - $63.0 $165,108 - $200,151
3,177 Added 6.77%
50,137 $3.01 Million
Q2 2020

Jul 22, 2020

BUY
$30.8 - $52.47 $417,340 - $710,968
13,550 Added 40.56%
46,960 $2.46 Million
Q1 2020

May 06, 2020

BUY
$28.4 - $50.7 $113,969 - $203,459
4,013 Added 13.65%
33,410 $1.12 Million
Q4 2019

Feb 03, 2020

SELL
$36.31 - $46.83 $1.23 Million - $1.58 Million
-33,769 Reduced 53.46%
29,397 $1.33 Million
Q3 2019

Nov 04, 2019

BUY
$35.66 - $44.99 $1.78 Million - $2.24 Million
49,780 Added 371.88%
63,166 $2.41 Million
Q2 2019

Jul 30, 2019

SELL
$36.57 - $47.97 $2.03 Million - $2.66 Million
-55,501 Reduced 80.57%
13,386 $582,000
Q1 2019

May 09, 2019

SELL
$36.47 - $42.17 $428,777 - $495,792
-11,757 Reduced 14.58%
68,887 $2.62 Million
Q4 2018

Feb 07, 2019

BUY
$41.31 - $52.16 $3.33 Million - $4.21 Million
80,644 New
80,644 $3.47 Million
Q2 2018

Aug 02, 2018

SELL
$27.5 - $39.8 $515,157 - $745,573
-18,733 Closed
0 $0
Q1 2018

Apr 23, 2018

BUY
$29.98 - $46.35 $561,615 - $868,274
18,733 New
18,733 $584,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.